Literature DB >> 15385692

C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults.

Edward C Suarez1.   

Abstract

OBJECTIVE: The current study examined the relation of anger, hostility, and severity of depressive symptoms, alone and in combination, to C-reactive protein (CRP) in healthy men and women.
METHODS: A high sensitivity enzyme linked immuno sorbent assay (ELISA) was used to evaluate CRP levels in a multiethnic sample of 127 healthy, nonsmoking men and women. Fasting blood samples were collected the same day the assessments were done of anger and hostility using the Buss-Perry Aggression Questionnaire (BPAQ) and depressive symptomatology using the Beck Depression Inventory (BDI). A psychological risk factor (PRF) score representing a composite summary indicator of BDI and BPAQ-anger and -hostility was generated using principal component analysis. Log-transformed CRP values were examined using univariate and multivariate analyses adjusting for control variables of age, gender, body mass index (BMI), alcohol use, exercise frequency, ratio of total to high-density lipoprotein cholesterol, and family history of premature coronary heart disease (CHD).
RESULTS: Log-normalized CRP was correlated with BDI (r = 0.21, p =.02) and BPAQ anger (r = 0.20, p =.02), but not with BPAQ hostility. After adjustment for control variables, BDI (beta = 0.05, p =.011), BPAQ anger (beta = 0.05, p =.007), and the PRF composite score (beta = 0.27, p =.005), but not BPAQ hostility (beta = 0.03, p =.11), were significantly associated with log-normalized CRP.
CONCLUSIONS: Greater anger and severity of depressive symptoms, separately and in combination with hostility, were significantly associated with elevations in CRP in apparently healthy men and women. These associations were independent of potential confounding factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385692     DOI: 10.1097/01.psy.0000138281.73634.67

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  41 in total

1.  Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder.

Authors:  Emil F Coccaro; Royce Lee; Elizabeth C Breen; Michael R Irwin
Journal:  Psychiatry Res       Date:  2015-07-29       Impact factor: 3.222

2.  Depressive symptoms in patients with obstructive sleep apnea: biological mechanistic pathways.

Authors:  Diana A Chirinos; Indira Gurubhagavatula; Preston Broderick; Julio A Chirinos; Karen Teff; Thomas Wadden; Greg Maislin; Hassam Saif; Jesse Chittams; Caitlin Cassidy; Alexandra L Hanlon; Allan I Pack
Journal:  J Behav Med       Date:  2017-06-21

3.  Trait anger, cynical hostility and inflammation in Latinas: variations by anger type?

Authors:  S Shivpuri; L C Gallo; P J Mills; K A Matthews; J P Elder; G A Talavera
Journal:  Brain Behav Immun       Date:  2011-05-01       Impact factor: 7.217

4.  Association between depression and inflammation--differences by race and sex: the META-Health study.

Authors:  Alanna Amyre Morris; Liping Zhao; Yusuf Ahmed; Neli Stoyanova; Christine De Staercke; William Craig Hooper; Gary Gibbons; Rebecca Din-Dzietham; Arshed Quyyumi; Viola Vaccarino
Journal:  Psychosom Med       Date:  2011-06-28       Impact factor: 4.312

5.  Leptin and its association with somatic depressive symptoms in patients with the metabolic syndrome.

Authors:  Diana A Chirinos; Ronald Goldberg; Marc Gellman; Armando J Mendez; Miriam Gutt; Judith R McCalla; Maria M Llabre; Neil Schneiderman
Journal:  Ann Behav Med       Date:  2013-08

6.  Replication and reproducibility issues in the relationship between C-reactive protein and depression: A systematic review and focused meta-analysis.

Authors:  Sarah R Horn; Madison M Long; Benjamin W Nelson; Nicholas B Allen; Philip A Fisher; Michelle L Byrne
Journal:  Brain Behav Immun       Date:  2018-06-19       Impact factor: 7.217

7.  Workplace based mindfulness practice and inflammation: a randomized trial.

Authors:  William B Malarkey; David Jarjoura; Maryanna Klatt
Journal:  Brain Behav Immun       Date:  2012-10-16       Impact factor: 7.217

8.  Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder.

Authors:  Angelo B Cunha; Ana C Andreazza; Fabiano A Gomes; Benicio N Frey; Leonardo E da Silveira; Carlos A Gonçalves; Flávio Kapczinski
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-02-23       Impact factor: 5.270

9.  Depressive symptoms and levels of C-reactive protein: a population-based study.

Authors:  Hynek Pikhart; Jaroslav A Hubacek; Ruzena Kubinova; Amanda Nicholson; Anne Peasey; Nada Capkova; Rudolf Poledne; Martin Bobak
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-08-11       Impact factor: 4.328

10.  The prospective association of socioeconomic status with C-reactive protein levels in the CARDIA study.

Authors:  Denise Janicki Deverts; Sheldon Cohen; Preety Kalra; Karen A Matthews
Journal:  Brain Behav Immun       Date:  2012-08-03       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.